(Reuters) - Johnson & Johnson posted better-than-expected third-quarter earnings, raising its full-year forecast due to growth from new cancer drugs and high-margin treatments picked up in its $30.. Reuters
(Reuters) - Johnson & Johnson reported a higher-than-expected quarterly profit and raised its full-year forecast, driven by strong demand for its new cancer drugs and gains from its acquisition of.. Reuters
Jun.26 -- Alex Gorsky, chairman and chief executive officer at Johnson & Johnson, discusses the company’s purchase of Actelion, the state of health care in the United States, and what tax reform.. Source: Bloomberg Politics -
Feb.06 -- Bloomberg’s Jeff McCracken discusses global deal activity in January, President Trump’s tax proposals and mergers and acquisitions in an unpredictable market. He speaks on “Bloomberg.. Source: Bloomberg Global Business -
Johnson & Johnson is enacting at $30 billion takeover of Europe’s biggest biotech company, Actelion. Johnson & Johnson is known for buying Swiss medical companies, and those who own stock in the.. Source: Wochit Headline News -
The European Commission today approved the planned sale of Swiss pharmaceuticals firm Actelion to Johnson & Johnson (J&J), subject to conditions.
EU regulators qualified the sale of Europe's biggest.. City A.M.
BRUSSELS (Reuters) - EU antitrust regulators approved on Friday Johnson & Johnson's planned purchase of Actelion Pharmaceutical subject to conditions intended to ensure clinical development of insomnia.. Reuters
ZURICH (Reuters) - Swiss biotechnology company Actelion on Thursday presented mixed trial results for its antibiotic hopeful cadazolid, saying it met the main goal of one late-stage study but failed to.. Reuters
ZURICH (Reuters) - The European Medicines Agency on Friday gave its green light for doctors to continue using Actelion's Uptravi, saying a review after five patient deaths in France did not suggest an.. Reuters
ZURICH (Reuters) - Johnson & Johnson declared its $30 billion tender offer for Swiss biotechnology company Actelion successful on Friday, reporting it controlled 77.2 percent of the voting rights after.. Reuters
Global M&A activity so far this year is at its highest level since the financial crisis, expert analysis has revealed.
Some $705bn of deals have been announced since the start of 2017, the first.. City A.M.